Document is current
Any future updates will be listed below
-
Authors
Sianoya, Abraham C. https://orcid.org/0000-0002-5070-7843
Ornos, Eric David B. https://orcid.org/0000-0001-6300-0292
Santos, Jerico R. https://orcid.org/0000-0002-7667-4373
Tantengco, Ourlad Alzeus G. https://orcid.org/0000-0002-4535-8837
Jimeno, Cecilia A. https://orcid.org/0000-0002-7658-0123
- License Information
-
More Information
Article History
Received: 20 June 2022
Accepted: 8 July 2022
First Online: 25 August 2022
Declarations
:
: Dr. Jimeno receives payment or honoraria from Sanofi Aventis, MSD Philippines, Novartis Philippines, and Merck for lectures/presentations/speakers bureaus/manuscript writing/educational events. She is also a member of the Technical Review Panel of the University of the Philippines, NIH, FDA, and a member of the Board of Directors for Philippine Lipid and Atherosclerosis Society. Mr. Sianoya, Mr. Ornos, Dr. Santos, and Dr. Tantengco declare that they have no conflict of interest.
